Skip to content

The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome

The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04542538
Enrollment
9905
Registered
2020-09-09
Start date
2018-04-11
Completion date
2021-01-11
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Human, Corona Virus Infection, Sepsis

Brief summary

The Corona virus disease 2019 (COVID-19) pandemic is currently involving all parts of the world. Several risk factors for critical illness and death from the disease have been proposed. However, it is still unclear if the observed associations between different comorbidities and chronic medications and severe COVID-19 disease and mortality is different from associations between the same factors and other severe diseases requiring intensive care unit (ICU) -care. This is important since some of the observed risk factors are very common in the aged who, by age alone, are more prone to a more severe course of any disease. By combining several registries, this study will compare, on several comorbidities such as hypertension and diabetes , the first 2000 cases of COVID-19 patients receiving critical care in Sweden to a Swedish sepsis-cohort and a Swedish adult respiratory distress syndrome (ARDS) -cohort.

Detailed description

The Corona virus disease 2019 (COVID-19) pandemic is currently involving all parts of the world. Several risk factors for critical illness and death from the disease have been proposed. However, it is still unclear if the observed associations between different comorbidities and chronic medications and severe COVID-19 disease and mortality is different from associations between the same factors and other severe diseases requiring ICU-care. This is important since some of the observed risk factors are very common in the aged who, by age alone, are more prone to a more severe course of any disease. By combining several registries, this study will compare, on several comorbidities such as hypertension and diabetes , the first 2000 cases of COVID-19 patients receiving critical care in Sweden to a Swedish sepsis-cohort and a Swedish ARDS-cohort.

Interventions

Sponsors

Center for Clinical Research Dalarna, Sweden
CollaboratorOTHER
Uppsala University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

° Individual registered in the Swedish intensive care registry (SIR) with COVID-19 Before 27 May 2020. or * Individual registered in the SIR with Severe sepsis or septic chock 2011-2016. or * Individual registered in the SIR with ARDS 2011-2016.

Exclusion criteria

* Age below 18 years * Individual registered in the Swedish intensive care registry without a personal identification number

Design outcomes

Primary

MeasureTime frameDescription
Risk factors of ICU care COVID-19/SepsisFive years preceding ICU admission to ICU admissionIn a binary logistics model with the outcome Sepsis or COVID-19 the OR for several comorbidities are determined.
Risk factors of ICU care COVID-19/ARDSFive years preceding ICU admission to ICU admissionIn a binary logistics model with the outcome ARDS or COVID-19 the OR for several comorbidities are determined.
Risk factors of ICU mortality COVID-19/SepsisFive years preceding ICU admission to ICU dischargeIn a Cox proportional hazards model with the outcome ICU-mortality the hazard ratio (HR) for the interaction between several comorbidities and a binary variable COVID-19/Sepsis are determined.
Risk factors of ICU mortality COVID-19/ARDSFive years preceding ICU admission to ICU dischargeIn a Cox proportional hazards model with the outcome ICU-mortality the HR for the interaction between several comorbidities and a binary variable COVID-19/ARDS are determined.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026